Anxious and depressive disorders and their comorbidity: Effect on central nervous system noradrenergic function

Biological Psychiatry

Volumn 56, Issue 11, 2004, Pages 875-883

  Cameron, Oliver G ^a,c   Abelson, James L ^a   Young, Elizabeth A ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NONE   (United States)

Author keywords

Anxiety; clonidine; comorbidity; depression; growth hormone; noradrenergic

Indexed keywords

ANTIDEPRESSANT AGENT; CLONIDINE; GROWTH HORMONE;

ADULT; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENSTRUAL CYCLE; NORADRENERGIC SYSTEM; PANIC; PRIORITY JOURNAL; SOCIAL PHOBIA; WEIGHT;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; ANXIETY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM; CLONIDINE; COMORBIDITY; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GROWTH HORMONE; HUMANS; MALE; NOREPINEPHRINE; PAIN MEASUREMENT; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; REGRESSION (PSYCHOLOGY); SLEEP STAGES;

EID: 9644281103     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.08.007     Document Type: Article

References (95)

1. J.L. Abelson, G.C. Curtis, T.W. Uhde Twenty-four hour growth hormone secretion in patients with panic disorder Psychoneuroendocrinology 30 2005 72 79
2. J.L. Abelson, D. Glitz, O.G. Cameron, M.A. Lee, M. Bronzo, G.C. Curtis Blunted growth hormone response to clonidine in patients with generalized anxiety disorder Arch Gen Psychiatry 48 1991 157 162
3. J.L. Abelson, D. Glitz, O.G. Cameron, M.A. Lee, M. Bronzo, G.C. Curtis Endocrine, cardiovascular and behavioral responses to clonidine in patients with panic disorder Biol Psychiatry 32 1992 18 25
4. J.M. Abplanalp, L. Livingston, R.M. Rose, D. Sandwisch Cortisol and growth hormone responses to psychological stress during the menstrual cycle Psychosom Med 39 1977 158 177
5. L. Altomonte, A. Zoli, L. Mirone, M. Berchicci, R. Travaglini, P. Pellicano, A.V. Greco Impaired growth hormone response to clonidine in obesity Exper Clin Endocrinol 92 1988 231 234
6. J.D. Amsterdam, G. Maislin Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness Biol Psychiatry 28 1990 308 314
7. J.D. Amsterdam, G. Maislin, P. Gold, A. Winokur The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness Psychoneuroendocrinology 14 1989 43 62
8. J.D. Amsterdam, G. Maislin, B. Skolnick, N. Berwish, A. Winokur Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers Biol Psychiatry 26 1989 265 278
9. M. Ansseau, R. Von Frenckell, J.L. Cerfontaine, P. Papart, G. Franck, M. Timsit-Berthier Blunted response of growth hormone to clonidine and apomorphine in endogenous depression Br J Psychiatry 153 1988 65 71
10. G. Aston-Jones, J. Rajkowski, J. Cohen Role of locus coeruleus in attention and behavioral flexibility Biol Psychiatry 46 1999 1309 1320
11. J. Balldin, U. Berggren, E. Eriksson, G. Lindstedt, A. Sundkler Guanfacine as an alpha-2-agonist inducer of growth hormone secretiona comparison with clonidine Psychoneuroendocrinology 18 1993 45 55
12. R. Balon, V.K. Yeragani, R. Pohl, J. Muench, R. Berchou Somatic and psychological symptoms during isoproterenol-induced panic attacks Psychiatry Res 32 1990 103 112
13. C.M. Bamberger, H. Monig, G. Mill, E. Godde, H.M. Schulte Growth hormone secretion in response to a new centrally acting antihypertensive agent moxonidine in normal human subjects Comparison to clonidine Exper Clin Endocrinol Diab 103 1995 205 208
14. J.G. Barbee Mixed symptoms and syndromes of anxiety and depression Diagnostic, prognostic and etiologic issues Ann Clin Psychiatry 10 1998 15 29
15. P. Bousquet, M. Dontenwill, H. Greney, J. Feldman I1-imidazoline receptors An update J Hypertension 16 suppl 1998 S1 S5
16. P. Boyer Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand 406 suppl 2000 24 29
17. F. Brambilla, G. Perna, A. Garberi, P. Nobile, L. Bellodi Alpha 2-adrenergic receptor sensitivity in panic disorder I GH responses to GHRH and clonidine stimulation in panic disorder Psychoneuroendocrinology 20 1995 1 9
18. J.D. Bremner, J.H. Krystal, S.M. Southwick, D.S. Charney Noradrenergic mechanisms in stress and anxiety I Preclinical studies Synapse 23 1996 28 38
19. W.A. Brown, G. Heninger Cortisol, growth hormone, free fatty acids and experimentally evoked affective arousal Am J Psychiatry 132 1975 1172 1176
20. O.G. Cameron The symptoms of adrenergic activation O.G. Cameron Adrenergic Dysfunction and Psychobiology 1994 American Psychiatric Press Washington, DC 237 255
21. O.G. Cameron, M.A. Lee, G. Curtis, D.S. McCann Endocrine and physiological changes during "spontaneous" panic attacks Psychoneuroendocrinology 12 1987 321 331
22. O.G. Cameron, S. Minoshima Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humans Psychosom Med 64 2002 851 861
23. O.G. Cameron, R.M. Nesse Systemic hormonal and physiological abnormalities in anxiety disorders Psychoneuroendocrinology 13 1988 287 307
24. O.G. Cameron, J.K. Zubieta, L. Grunhaus, S. Minoshima Effects of yohimbine on cerebral blood flow, symptoms and physiological functions in humans Psychosom Med 62 2000 549 559
25. D.S. Charney, G.R. Heninger, A. Breier Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder Arch Gen Psychiatry 41 1984 751 763
26. D.S. Charney, G.R. Heninger, D.E. Sternberg Failure of chronic antidepressant treatment to alter growth hormone response to clonidine Psychiatry Res 7 1982 135 138
27. D.S. Charney, G.R. Heninger, D.E. Sternberg, K.M. Hafstad, S. Giddings, D.H. Landis Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects Arch Gen Psychiatry 39 1982 290 294
28. D.S. Charney, S.W. Woods, J.H. Krystal, L.M. Nagy, G.R. Heninger Noradrenergic neuronal dysregulation in panic disorder The effects of intravenous yohimbine and clonidine in panic disorder patients Acta Psychiatr Scand 86 1992 273 282
29. S.A. Checkley, I.B. Glass, C. Thompson, T. Corn, P. Robinson The GH response to clonidine in endogenous as compared with reactive depression Psychol Med 14 1984 773 777
30. S.A. Checkley, A.P. Slade, E. Shur Growth hormone and other responses to clonidine in patients with endogenous depression Br J Psychiatry 138 1981 51 55
31. J.D. Coplan, L.A. Papp, J. Martinez, D. Pine, L.A. Rosenblum, T. Cooper Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder Am J Psychiatry 152 1995 619 622
32. H. Correa, F. Duval, M.M. Claude, P. Bailey, F. Tremeau, T.S. Diep Noradrenergic dysfunction and antidepressant treatment response Europ Neuropsychopharmacol 11 2001 163 168
33. G.C. Curtis, R. Nesse, M. Buxton, D. Lippman Plasma growth hormone Effect of anxiety during flooding in vivo Am J Psychiatry 136 1979 410 414
34. I.C. Fedoroff, S. Taylor Psychological and pharmacological treatments of social phobia A meta-analysis J Clin Psychopharmacol 21 2001 311 324
35. F. Fornai, C. Blandizzi, M. del Tacca Central alpha-2 adrenoceptors regulate central and peripheral functions Pharmacol Res 22 1990 541 554
36. L.A. Frohman, T.R. Downs, P. Chomczynski Regulation of growth hormone secretion Front Neuroendocrinol 13 1992 344 405
37. C.H. Fu, L.J. Reed, J.H. Meyer, S. Kennedy, S. Houle, B.S. Eisfeld, G.M. Brown Noradrenergic dysfunction in the prefrontal cortex in depression An [15O]H2O PET study of the neuromodulatory effects of clonidine Biol Psychiatry 49 2001 317 325
38. H. Gann, D. Riemann, S. Stoll, M. Berger, W.E. Muller Growth hormone response to growth hormone-releasing hormone and clonidine in depression Biol Psychiatry 38 1995 325 329
39. J. Gelernter, G.P. Page, M.B. Stein, S.W. Woods Genome-wide linkage scan for loci predisposing to social phobia Evidence for a chromosome 16 risk linkage Am J Psychiatry 161 2004 59 66
40. I. Gil-Ad, R. Gurewitz, O. Marcovici, J. Rosenfeld, Z. Laron Effect of aging on human plasma growth hormone response to clonidine Mech Ageing Dev 27 1984 97 9100
41. P.W. Gold, G.P. Chrousos Organization of the stress system and its dysregulation in melancholic and atypical depression High versus low CRH/NE states Molec Psychiatry 7 2002 254 275
42. G.N. Gurguis, B.J. Vitton, T.W. Uhde Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls Psychiatry Res 71 1997 27 39
43. Z. Harel, G.S. Tannenbaum Synergistic interactions between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion Endocrinology 131 1992 758 764
44. G.M. Hasey, H.C. Stancer, J.J. Warsh, E. Persad Neurotransmitter metabolities and endocrine responses in depression Prog Neuropsychopharmacol Biol Psychiatry 9 1985 613 617
45. E. Hollander, C. DeCaria, A. Nitescu, T. Cooper, B. Stover, R. Gully Noradrenergic function in obsessive-compulsive disorder Behavioral and neuroendocrine responses to clonidine and comparison to health controls Psychiatry Res 37 1991 161 177
46. R.W. Horton, C.L. Katona, A.E. Theodorou, A.S. Hale, S.L. Davies, C. Tunnicliffe Platelet radioligand and neuroendocrine challenge tests in depression Ciba Found Symp 123 1986 84 8105
47. M.R. Johnson, R.B. Lydiard The neurobiology of anxiety disorders Psychiatr Clin North Am 18 1995 681 725
48. C.L. Katona, D. Healy, E.S. Paykel, A.E. Theodorou, K.M. Lawrence, A. Whitehouse Growth hormone and physiological responses to clonidine in depression Psychol Med 23 1993 57 63
49. R.C. Kessler, K.A. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, S. Eschleman Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Arch Gen Psychiatry 51 1994 8 19
50. R.C. Kessler, P. Stang, H.U. Wittchen, M. Stein, E.E. Walters Lifetime co-morbidities between social phobia and mood disorders in the US national comorbidity survey Psychol Med 29 1999 555 567
51. R.C. Kessler, P.E. Stang, H.U. Wittchen, T.B. Ustun, P.P. Roy-Byrne, E.E. Walters Lifetime panic-depression comorbidity in the national comorbidity survey Arch Gen Psychiatry 55 1998 801 808
52. J. Kimber, M. Sivenandan, L. Watson, C.J. Mathias Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults Growth Horm Igf Res 11 2001 128 135
53. S.J. Kiraly, R.J. Ancill, G. Dimitrova The relationship of endogenous cortisol to psychiatric disorder A review Can J Psychiatry 42 1997 415 420
54. C. Kirschbaum, K.M. Pirke, D.H. Hellhammer The "Trier Social Stress Test"a tool for investigating psychobiological stress responses in a laboratory setting Neuropsychobiology 28 1993 76 81
55. G.F. Koob Corticotropin-releasing factor, norepinephrine and stress Biol Psychiatry 46 1999 1167 1180
56. T.R. Kosten, S. Jacobs, J. Mason, V. Wahby, S. Atkins Psychological correlates of growth hormone response to stress Psychosom Med 46 1984 49 58
57. M. Lader Beta-adrenoceptor antagonists in neuropsychiatry An update J Clin Psychiatry 49 1988 213 223
58. M.A. Lee, O.G. Cameron, G.N. Gurguis, D. Glitz, C.B. Smith, M. Hariharan Alpha 2-adrenoreceptor status in obsessive-compulsive disorder Biol Psychiatry 27 1990 1083 1093
59. R.B. Lydiard Coexisting depression and anxiety Special diagnostic and treatment issues J Clin Psychiatry 52 suppl 1991 48 54
60. N. Matussek, M. Ackenheil, H. Hippius, F. Muller, H.T. Schroder, H. Schultes Effect of clondine on growth hormone release in psychiatric patients and controls Psychiatry Res 2 1980 25 36
61. N. Matussek, G. Laakmann Growth hormone response in patients with depression Acta Psychiatr Scand 290 suppl 1981 122 126
62. J. Mendlewicz, P. Linkowski, M. Kerkhofs, D. Desmedt, J. Golstein, G. Copinschi, E. Van Cauter Diurnal hypersecretion of growth hormone in depression J Clin Endocrinol Metab 60 1985 505 512
63. P. Mitchell, G. Smythe, G. Parker, K. Wilhelm, H. Brodaty, I. Hickie Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls Psychiatry Res 37 1991 179 193
64. P.B. Mitchell, J.A. Bearn, T.H. Corn, S.A. Checkley Growth hormone response to clonidine after recovery in patients with endogenous depression Br J Psychiatry 152 1988 34 38
65. P. Morris, M. Hopwood, K. Maguire, T. Norman, I. Schweitzer Blunted growth hormone response to clonidine in post-traumatic stress disorder Psychoneuroendocrinology 29 2004 269 278
66. R.M. Nesse, O.G. Cameron, G.C. Curtis, D.S. McCann, M.J. Huber-Smith Adrenergic function in patients with panic anxiety Arch Gen Psychiatry 41 1984 771 776
67. G.L. Noel, R.C. Dimond, J.M. Earll, A.G. Frantz Prolactin, thyrotropin and growth hormone release during stress associated with parachute jumping Aviat Space Environ Med 47 1976 543 547
68. J.E. Piletz, A. Halaris, J. Nelson, Y. Qu, M. Bari Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety J Psychiatr Res 30 1996 147 168
69. S. Regunathan, D.J. Reis Imidazoline receptors and their endogenous ligands Annu Rev Pharmacol Toxicol 36 1996 511 544
70. S. Reichlin Neuroendocrinology of the pituitary gland Toxicol Path 17 1989 250 255
71. K.J. Ressler, C.B. Nemeroff Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders Depr Anx 12 suppl 1 2000 2 19
72. T.W. Robbins Cortical noradrenaline, attention and arousal Psychol Med 14 1984 13 21
73. R.M. Rose, M.W. Hurst Plasma cortisol and growth hormone responses to intravenous catheterization J Human Stress 1 1975 22 36
74. P.P. Roy-Byrne, P. Stang, H.U. Wittchen, B. Ustun, E.E. Walters, R.C. Kessler Lifetime panic-depression comorbidity in the national comorbidity survey. Associations with symptoms, impairment, course and help-seeking Br J Psychiatry 176 2000 229 235
75. S.G. Schafer, E.C. Kaan, M.O. Christen, A. Low-Kroger, H.J. Mest, G.J. Molderings Why imidazoline receptor modulator in the treatment of hypertension? Ann N Y Acad Sci 763 1995 659 672
76. M. Schittecatte, M. Ansseau, G. Charles, R. Machowski, P. Papart, W. Pichot, J. Wilmotte Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants Psychol Med 22 1992 1059 1062
77. M. Schittecatte, G. Charles, R. Machowski, J. Wilmotte Tricyclic wash-out and growth hormone response to clonidine Br J Psychiatry 154 1989 858 863
78. H.J. Schneider, U. Pagatto, G.K. Stalla Central effects of the somatotropic system Europ J Endocrinol 149 2003 377 392
79. M.K. Shear Pathophysiology of panic A review of pharmacologic provocative tests and naturalistic monitoring data J Clin Psychiatry 47 suppl 1986 18 26
80. L.J. Siever, T.R. Insel, D.C. Jimerson, C.R. Lake, T.W. Uhde, J. Aloi, D.L. Murphy Growth hormone response to clonidine in obsessive-compulsive disorder Br J Psychiatry 142 1983 184 187
81. L.J. Siever, T. Insel, T. Uhde Noradrenergic challenges in the affective disorders J Clin Psychopharmacol 1 1981 193 206
82. L.J. Siever, R.L. Trestman, E.F. Coccaro, D. Bernstein, S.M. Gabriel, K. Owen The growth hormone response to clonidine in acute and remitted depressed male patients Neuropsychopharmacology 6 1992 165 177
83. L.J. Siever, T.W. Uhde New studies and perspectives on the noradrenergic receptor system in depression Effects of the alpha 2-adrenergic agonist clonidine Biol Psychiatry 19 1984 131 156
84. S.C. Stanford Central noradrenergic neurons and stress Pharmacol Therap 68 1995 297 342
85. M.B. Stein, M.E. Tancer, T.W. Uhde Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects Arch Gen Psychiatry 49 1992 311 317
86. G.M. Sullivan, J.D. Coplan, J.M. Kent, Gorman The noradrenergic system in pathological anxiety A focus on panic with relevance to generalized anxiety and phobias Biol Psychiatry 46 1999 1205 1218
87. M. Tanaka, M. Yoshida, H. Emoto, H. Ishii Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety Basic studies review Eur J Pharmacol 405 2000 397 406
88. M.E. Tancer, R.B. Mailman, M.B. Stein, G.A. Mason, S.W. Carson, R.N. Golden Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia Anxiety 1 1994 16 23 -95
89. M.E. Tancer, M.B. Stein, T.W. Uhde Growth hormone (GH) response to clonidine and growth-hormone releasing factor (GRF) in normal controls Psychoneuroendocrinology 15 1990 253 259
90. M.E. Tancer, M.B. Stein, T.W. Uhde Growth hormone response to intravenous clonidine in social phobia Comparison to patients with panic disorder and healthy volunteers Biol Psychiatry 34 1993 591 595
91. P. Tyrer Current status of beta-blocking drugs in the treatment of anxiety disorders Drugs 36 1988 773 783
92. M. Van Ameringen, C. Allgulander, B. Bandelow, J.H. Greist, E. Hollander, S.A. Montgomery WCA recommendations for the long-term treatment of social phobia CNS Spectr 8 8 suppl 2003 40 52
93. S.W. Woods, D.S. Charney, C.A. McPherson, A.H. Gradman, G.R. Heninger Situational panic attacks. Behavioral, physiologic and biochemical characterization Arch Gen Psychiatry 44 1987 365 375
94. E.A. Young, J.L. Abelson, O.G. Cameron Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression Biol Psychiatry 56 2004 113 120
95. E.A. Young, R.F. Haskett, L. Grunhaus, A. Pande, V.M. Weinberg, S.J. Watson, H. Akil Increased evening activation of the hypothalamic-pituitary- adrenal axis in depressed patients Arch Gen Psychiatry 51 1994 701 707